Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-210940
Filing Date
2020-08-06
Accepted
2020-08-05 19:55:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d949204d424b5.htm 424B5 349630
2 GRAPHIC g949204g76n76.jpg GRAPHIC 45522
3 GRAPHIC g949204g85h57.jpg GRAPHIC 43168
  Complete submission text file 0001193125-20-210940.txt   472910
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-224418 | Film No.: 201079333
SIC: 2836 Biological Products, (No Diagnostic Substances)